deferiprone has been researched along with Becker Muscular Dystrophy in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Deferiprone treatment tended to decrease muscle iron levels in mdx mice (-30%, P < 0." | 1.72 | Iron overload and impaired iron handling contribute to the dystrophic pathology in models of Duchenne muscular dystrophy. ( Alves, FM; Ayton, S; Bush, AI; Caldow, MK; Chung, JD; Crouch, PJ; Hardee, JP; Hare, DJ; Koopman, R; Kysenius, K; Lynch, GS; Trieu, J, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, FM | 1 |
| Kysenius, K | 1 |
| Caldow, MK | 1 |
| Hardee, JP | 1 |
| Chung, JD | 1 |
| Trieu, J | 1 |
| Hare, DJ | 1 |
| Crouch, PJ | 1 |
| Ayton, S | 1 |
| Bush, AI | 1 |
| Lynch, GS | 1 |
| Koopman, R | 1 |
1 other study available for deferiprone and Becker Muscular Dystrophy
| Article | Year |
|---|---|
Iron overload and impaired iron handling contribute to the dystrophic pathology in models of Duchenne muscular dystrophy.
Topics: Animals; Deferiprone; Dystrophin; Ferritins; Fibrosis; Heme; Iron; Iron Chelating Agents; Iron Overl | 2022 |